分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants

Sun Cong, Kang Yin-Feng, Liu Yuan-Tao, Kong Xiang-Wei, Xu Hui-Qin, Xiong Dan, Xie Chu, Liu Yi-Hao, Peng Sui, Feng Guo-Kai, Liu Zheng, Zeng Mu-Sheng

Journal:Signal Transduction and Targeted Therapy

IF:38.1

DOI:10.1038/s41392-022-00910-6

PMID:35136040

Published:2022-02-08

research field:

Abstract

SARS-CoV-2 variants have evolved a variety of critical mutations, leading to antigenicity changes and immune escape. The recent emerging SARS-CoV-2 Omicron variant attracted global attention due to its significant resistance to current antibody therapies and vaccines. Here, we profiled the mutations of Omicron and other various circulating SARS-CoV-2 variants in parallel by computational interface analysis and in vitro experimental assays. We identified critical mutations that lead to antigenicity changes and diminished neutralization efficiency of a panel of 14 antibodies due to diverse molecular mechanisms influencing the antigen-antibody interaction. Our study identified that Omicron exhibited extraordinary potency in immune escape compared to the other variants of concern, and explores the application of computational interface analysis in SARS-CoV-2 mutation surveillance and demonstrates its potential for the early identification of concerning variants, providing preliminary guidance for neutralizing antibody therapy.

本文使用的Yeasen产品

购物车
客服
转染试用